Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson’s Disease: Rationale for Clinical Trial, and Current Progress

Camille B. Carroll, Richard K.H. Wyse*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Downloads (Pure)
Original languageEnglish
Number of pages0
JournalJournal of Parkinson's Disease
Volume0
Issue number0
Early online date13 Oct 2017
DOIs
Publication statusPublished - 13 Oct 2017

Cite this